CODES,DISPLAY,TEXT,SKIP,CONTENT,FEEDBACK,LOGIN,QUICK,SEARCH,BILL,INFORMATION,CALIFORNIA LAW,PUBLICATIONS,RESOURCES,FAVORITES,CODE,SECTION,GROUP CODE,SELECT,HEALTH AND SAFETY,PRESCRIPTION DRUG,PROHIBITION,DIVISION,EXCEPT,SECTION 132,PERSON,SHALL,THE STATE,PRODUCT,VOUCHER,REDUCTION,INDIVIDUALS,OUT OF POCKET EXPENSES,HIS OR HER,HEALTH INSURANCE,HEALTH CARE SERVICE,PLAN,HEALTH,COVERAGE,LIMITED,COPAYMENT,COINSURANCE,DEDUCTIBLE,COST,GENERIC DRUG,COST SHARING,TIER,DESIGNATED,EQUIVALENT,AS INDICATED,THE UNITED STATES,FOOD,DRUG,APPROVED DRUG PRODUCTS WITH,THERAPEUTIC,EQUIVALENCE,THE PROHIBITION,SUBDIVISION,APPLY,BRANDED,NATIONALLY,AVAILABLE,CALENDAR,MONTHS,EFFECTIVE,JANUARY 1,ACTIVE INGREDIENTS,REGULATED,THE FEDERAL,FOOD AND DRUG ADMINISTRATION,PRESCRIPTION,THE CONDITION,PAYMENT,PATIENT,PATIENTS,BEHALF,UNITED STATES FOOD AND DRUG,ADMINISTRATION,RISK EVALUATION AND MITIGATION,STRATEGY,PURPOSE,MONITORING,FACILITATING,MANNER,CONSISTENT,LABELING,TABLET,REGIMEN,PREVENTION OF HUMAN,IMMUNODEFICIENCY,VIRUS,HIV,ACQUIRED IMMUNE DEFICIENCY,SYNDROME,AIDS,UNLESS,GUIDELINES,PEER REVIEWED SCIENTIFIC,MEDICAL LITERATURE,ADHERENCE,C,STEP THERAPY,PRIOR AUTHORIZATION,REQUIREMENTS,HEALTH INSURER,STATE AGENCY,ENTITY,PRESCRIPTION DRUGS,ASSISTANCE,PROGRAM,MANUFACTURERS,OFFERING,PHARMACEUTICAL PRODUCT,FREE,THE PRODUCT,FREE OF COST,THE PATIENT,AFFECT,PHARMACISTS,ABILITY,SUBSTITUTE,THE BUSINESS,CODE B,LIMIT,INDEPENDENT,CHARITY,PROGRAM 2,MEANS,THE PROGRAM,PHARMACEUTICAL MANUFACTURER,AFFILIATE,MANUFACTURER,EMPLOYEE,AGENT,OFFICER,SHAREHOLDER,WHOLESALER,DISTRIBUTOR,PHARMACY,BENEFITS,MANAGER,DIRECT,INFLUENCE,CONTROL,SUBSIDY,AWARDED,TRULY,LINK,PHARMACEUTICAL MANUFACTURERS,FUNDING,BENEFICIARY,INTEREST,CHOICE,PROVIDER,REASONABLE,VERIFIABLE,UNIFORM MEASURE,FINANCIAL,NEED,SOLICIT,DATA,FACILITATE,AMOUNT,FREQUENCY,DONATIONS,NUMBER,SUBSIDIZED,SAFETY,